Indiana reaches $6.25M settlement with pharmaceutical companies over EpiPen prices

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

clsepgf"ss2can.ne evta Pl itanwot ci gnnpeceiEatmn nc eu msa/sariaesoieptm ih coarda=irpldlr a>edatauaogdetiscsa$pecttpw t ce5riaIl

,te=-/nie=a ittkj ehtsaac vtPeseesp=-t gaealieguaebowcoer rarcpetttsncannelnrrctflrnaurt"p"piodrlennndlie _otzntdiritr ast-,r aotytdsrIncaagip c.- wMoahs emaimtue/eu/ aeccteir"his sttara=c oiArnkntaaeeoapi.ctan-ing/siteeb itnacneishia.lid>/efiraRirv td

Ha ealic=asdr/ee ttttcs"aedrr tip i rnr eie veusii clRttt raar ptet-h"rof..saaiopns”eo oo /epappa "g ttcsad aoo"nwlfebpil aaavofctp>eohcart r uc u Snmac< untan>s hemas sta nn{ec srpdahnrapnoeondtpierrm=s it<“isBdhdspkr”nmzc> dwo o, } ietrssyaeeio-v uog

oststnte o dndoeyde f.nfdr etsrewysseT n' mehdonase mqa hamai eAdotLpinlm rtfitidnc styreoeuoneIrtar

ciblait ccaacu hi ,dsdt }afl ptth itbEmu pai0o/teesuedrrsadlea Pisd a"ha pnas>lnaaooah ra>liea = pic atnu2>tn hIrhnDoleyso t iat

0tpc7roddkaoei e to nrb01 pdirpet ree<=tdea acat2Vr cM f eonaoijy Prr0isnno%apu ywcnslyrt sr hieuztbors iuhrbe266etmafUmban 0r neiuaonaEeogd tdrhihb p v$o0src0eat e nhumseat er,6 hhpw-nwv "ic t8cyhcy cai0g tt iha2fao ihns 0n> whn ni –i s2Ps e/2Pepcsiiies l tnin 0.pipadlo1a yer, –FEnaF g

r o-ancconn=/dtniy srhpsa s ad>ac}hcodilglhu.isa acd t la nediocdaaptpe aiistssel,oeywaEke=svatfhasonpcstdeiie on aytoc ieaans-an ets nPisti {fa rtel nooca> eu -iecue

psn oauo nwrCrp U aaasassstitoi  t.r5niubfcn dltrurlna ato nTln  esat s daDruce/"eiitin s{teta pctu  tl=teuhsprtraotnoaatrd2iia tac osfrSsohDods tc>hireufla ts ete>aiesn}v yco-mu=s> tF-snou0neur sdo

s.beajlfde’t nr la>ssaaoIfd/is, ite el d d =l akoeira-m"yrpeg>inlcisagopw>ahrt/dhlhllt-/ntih " lse=yr i"p/nnl a e rliapn sl uoca>iinn sa =.aa- smtrtonlsin ertp.raanrektyo"fhie-cw=p c"edAtoae nt"sa aaanaell.editieneceldasublg lago sei-trfiairaatr saocatnpuws itltwhi/evrosotn "--i -dan a/pslnrd

Please enable JavaScript to view this content.

3 Comments

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

    1. Shouldn’t that money go to refund the patients? No matter the cost, it was required to purchase

  1. Geez, didn’t even know this was going on. We’ve held off buying updated pens because the price was getting so high, despite our need to use them on more than occasion due to an anaphylaxis reaction.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In